| scholarly article | Q13442814 |
| P2093 | author name string | Sophie A Fillon | |
| Mark A Lovell | |||
| Karim C El Kasmi | |||
| Milton J Finegold | |||
| Aimee L Anderson | |||
| Michael W Devereaux | |||
| Ronald J Sokol | |||
| J Kirk Harris | |||
| P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
| The role of inflammation in cholestasis: clinical and basic aspects | Q27694662 | ||
| TLR4 enhances TGF-beta signaling and hepatic fibrosis | Q29620016 | ||
| Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. | Q33786301 | ||
| n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases | Q34569101 | ||
| Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth | Q35606574 | ||
| Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases | Q35952464 | ||
| Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation | Q36351821 | ||
| Causes and management of intestinal failure in children | Q36394201 | ||
| Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-kappa B in vivo | Q36824357 | ||
| Signalling pathways in alcohol-induced liver inflammation. | Q37461766 | ||
| Intestinal endotoxins as mediators of hepatic injury--an idea whose time has come again | Q38710982 | ||
| Intestinal permeability in the newborn | Q38946722 | ||
| Intrahepatic cholestasis associated with parenteral nutrition in premature infants | Q39685351 | ||
| Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. | Q40108919 | ||
| Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome | Q41610809 | ||
| Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
| Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice | Q42586870 | ||
| Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora | Q44218058 | ||
| Alteration in epithelial permeability and ion transport in a mouse model of total parenteral nutrition | Q44394761 | ||
| Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. | Q45917922 | ||
| Intestinal permeability to small- and large-molecular-weight substances in the newborn rabbit | Q47297663 | ||
| II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin | Q50864303 | ||
| Microbial translocation in neonates and infants receiving long-term parenteral nutrition. | Q54594768 | ||
| Noninfectious colitis associated with short gut syndrome in infants | Q68306882 | ||
| Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set | Q77465460 | ||
| Lack of enteral nutrition--effects on the intestinal immune system | Q81278341 | ||
| Growth and development of an infant receiving all nutrients exclusively by vein | Q93763197 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 1518-1528 | |
| P577 | publication date | 2012-03-18 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury | |
| P478 | volume | 55 |
| Q34785717 | 2-phenylethynesulfonamide Prevents Induction of Pro-inflammatory Factors and Attenuates LPS-induced Liver Injury by Targeting NHE1-Hsp70 Complex in Mice |
| Q37499819 | A CARD9 polymorphism is associated with decreased likelihood of persistent conjugated hyperbilirubinemia in intestinal failure |
| Q28485918 | A Metabolomic Analysis of Two Intravenous Lipid Emulsions in a Murine Model |
| Q50199986 | A meta-analysis of clinical outcome of intestinal transplantation in patients with total intestinal aganglionosis |
| Q90266551 | Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota |
| Q34726758 | Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges |
| Q38395268 | Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure |
| Q35794573 | Changes to the Intestinal Microbiome With Parenteral Nutrition: Review of a Murine Model and Potential Clinical Implications |
| Q46738655 | Choline Alleviates Parenteral Nutrition-Associated Duodenal Motility Disorder in Infant Rats |
| Q26865276 | Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology |
| Q40333634 | Curcumin Protects Against Intestinal Origin Endotoxemia in Rat Liver Cirrhosis by Targeting PCSK9. |
| Q30241940 | Developmental origins of NAFLD: a womb with a clue |
| Q91844270 | Differential Metabolomic Analysis of Liver Tissues from Rat Models of Parenteral Nutrition-Associated Liver Disease |
| Q36480403 | Dysregulation of bile acid homeostasis in parenteral nutrition mouse model |
| Q33959776 | Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates |
| Q92047233 | Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial |
| Q35205341 | Enteral nutrient deprivation in patients leads to a loss of intestinal epithelial barrier function |
| Q43873401 | Enteral supplementation of bovine lactoferrin improves gut barrier function in rats after massive bowel resection |
| Q36598500 | Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3. |
| Q37376495 | Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy |
| Q36868107 | Human SR-BI and SR-BII Potentiate Lipopolysaccharide-Induced Inflammation and Acute Liver and Kidney Injury in Mice |
| Q38178585 | Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease |
| Q33663789 | Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation |
| Q35679248 | Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease |
| Q46631846 | Intravenous Fish Oil and Pediatric Intestinal Failure-Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids. |
| Q54977543 | Lactobacillus plantarum reverse diabetes-induced Fmo3 and ICAM expression in mice through enteric dysbiosis-related c-Jun NH2-terminal kinase pathways. |
| Q51591948 | Lipid Emulsion Formulation of Parenteral Nutrition Affects Intestinal Microbiota and Host Responses in Neonatal Piglets |
| Q35831623 | Lipopolysaccharide significantly influences the hepatic triglyceride metabolism in growing pigs |
| Q55408026 | Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis. |
| Q59794802 | Mechanisms of TQ-6, a Novel Ruthenium-Derivative Compound, against Lipopolysaccharide-Induced In Vitro Macrophage Activation and Liver Injury in Experimental Mice: The Crucial Role of p38 MAPK and NF-κB Signaling |
| Q38060388 | Neonatal short bowel syndrome as a model of intestinal failure: Physiological background for enteral feeding |
| Q89461040 | New Insights Into Intestinal Failure-Associated Liver Disease in Children |
| Q42368237 | Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota |
| Q53802509 | Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease. |
| Q45169013 | Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure. |
| Q35662655 | Physiology and pathophysiology of liver lipid metabolism. |
| Q33805839 | Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease |
| Q38931529 | Potential Hepatotoxicities of Intravenous Fat Emulsions in Infants and Children |
| Q55515253 | Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children. |
| Q42765644 | Prevention and treatment of intestinal failure-associated liver disease in children |
| Q94564532 | Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver |
| Q54261706 | Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. |
| Q54699275 | Raw bovine milk improves gut responses to feeding relative to infant formula in preterm piglets. |
| Q98165153 | Review of parenteral nutrition-associated liver disease |
| Q38851354 | Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosis |
| Q96953599 | Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection |
| Q92137356 | Short Bowel Syndrome as the Leading Cause of Intestinal Failure in Early Life: Some Insights into the Management |
| Q36775835 | Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation |
| Q34374168 | Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation |
| Q26780509 | The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease |
| Q88374758 | The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome |
| Q38789869 | The intestinal microbiome and paediatric liver disease |
| Q54392025 | The vagus nerve attenuates fulminant hepatitis by activating the Src kinase in Kuppfer cells |
| Q46299393 | Two-Year Neurodevelopment and Growth Outcomes for Preterm Neonates Who Received Low-Dose Intravenous Soybean Oil. |
Search more.